Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections
Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections have?
Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections has 63 citations in the OpenAlex counts ScholarIQ stores.
When was Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections published?
Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections has 2022 year in the ScholarIQ index.
What is the open-access status of Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections?
Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections has gold oa status in the ScholarIQ index.
What is the DOI of Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections?
The DOI for Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections is on the source record.
What is the PMID of Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections?
The PMID for Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections is on the source record.
What is the OpenAlex record for Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections?
The OpenAlex for Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections is on the source record.